Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma

• Main Authors: Yi Shi (Author), Dan-Dan Zhang (Author), Ji-Bin Liu (Author), Xiao-Li Yang (Author), Rui Xin (Author), Cheng-You Jia (Author), Hui-Min Wang (Author), Gai-Xia Lu (Author), Pei-Yao Wang (Author), Yu Liu (Author), Zi-Jin Li (Author), Jing Deng (Author), Qin-Lu Lin (Author), Liang Ma (Author), Shan-Shan Feng (Author), Xiao-Qi Chen (Author), Xiang-Min Zheng (Author), Ya-Fu Zhou (Author), Yong-Jun Hu (Author), Hua-Qun Yin (Author), Lin-Lin Tian (Author), Li-Peng Gu (Author), Zhong-Wei Lv (Author), Fei Yu (Author), Wen Li (Author), Yu-Shui Ma (Author), Fu Da (Author)
• Format: Book
• Published: Elsevier, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors that are harmful to human health. Increasing evidence has underscored the critical role of the competitive endogenous RNA (ceRNA) regulatory networks among various human cancers. However, the complexity and behavior characterist...